Literature DB >> 3232999

Somatostatin analogue in short term management of hyperinsulinism.

J M Kirk1, L Di Silvio, P C Hindmarsh, C G Brook.   

Abstract

Five infants with hypoglycaemia due to hyperinsulinism were treated for between three and 11 days with a somatostatin analogue, which raised the mean blood glucose concentration and lowered the glucose requirements in all. Somatostatin analogue appears to be useful in the short term management of these patients.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3232999      PMCID： PMC1779187          DOI： 10.1136/adc.63.12.1493

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Short-term management of nesidioblastosis using the somatostatin analogue SMS 201-995.

Authors:  P Hindmarsh; C G Brook
Journal:  N Engl J Med       Date:  1987-01-22       Impact factor: 91.245

2.  The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man.

Authors:  T E Adrian; A J Barnes; R G Long; D J O'Shaughnessy; M R Brown; J Rivier; W Vale; A M Blackburn; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  1981-10       Impact factor: 5.958

3.  Effect of somatostatin infusion on intermediary metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia.

Authors:  A Aynsley-Green; N D Barnes; T E Adrian; J Kingston; S Boyes; S R Bloom
Journal:  Acta Paediatr Scand       Date:  1981-11

4.  Hypoglycemia of infancy and nesidioblastosis. Studies with somatostatin.

Authors:  H J Hirsch; S Loo; N Evans; J F Crigler; R M Filler; K H Gabbay
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

5.  Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia.

Authors:  A Aynsley-Green; J M Polak; S R Bloom; M H Gough; J Keeling; S J Ashcroft; R C Turner; J D Baum
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791
  5 in total
  6 in total

1.  Somatostatin analogue in short term management of hyperinsulinism.

Authors:  S J Newell; M D Hocking; P H Rayner
Journal:  Arch Dis Child       Date:  1989-05       Impact factor: 3.791

2.  Growth and endocrine function after near total pancreatectomy for hyperinsulinaemic hypoglycaemia.

Authors:  A T Soliman; I Alsalmi; A Darwish; M G Asfour
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

Review 3.  Clinical use of the long acting somatostatin analogue octreotide in pediatrics.

Authors:  M T Tauber; A G Harris; P Rochiccioli
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

4.  Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood.

Authors:  L Spitz; R K Bhargava; D B Grant; J V Leonard
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

5.  The effects of a somatostatin analogue on the metabolism of an infant with Beckwith-Wiedemann syndrome and hyperinsulinaemic hypoglycaemia.

Authors:  W J Gerver; P P Menheere; C Schaap; P Degraeuwe
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

Review 6.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.